Searched for
GLAXOSMITHKLINE INTELLECTUAL PROPERTY LTD
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...- Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injectionAlembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatripta...
- Bombay HC dismisses HUL's plea for relief against TDS demand worth over Rs 963 croreThe Bombay High Court has dismissed Hindustan Unilever Limited's Writ Petition regarding a demand of INR 962.75 Crores by the Income Tax Au...
- HUL gets Rs 963 cr Income Tax demand noticeHindustan Unilever Limited (HUL) has received a Rs 962.75 crore tax demand from the Income Tax Department related to non-deduction of TDS o...
- HUL slapped with Rs 962 crore tax notice over TDS dispute in Rs 3,045 crore GlaxoSmithKline dealHindustan Unilever has received a tax demand of Rs 962.75 crore from the Income Tax Department over non-deduction of TDS for acquiring inte...
- GSK files patent suit against GlenmarkGSK was granted a patent for vilanterol in India in 2007. The patent expires in September 2022.
- MNCs remain D-Street’s consistent wealth creators through thick & thinMNCs in India are those in which foreign shareholding is in excess of 50 per cent and/or management control is vested in a foreign company.
- Gilead’s drug leads global race to find virus treatmentThe update on the trials’ progress came a day after the World Health Organization said that remdesivir may be the only effective treatment ...
- GSK to fund doctoral programs at Regional Centre for BiotechnologyStudents with a master’s degree in biostatistics, maths, statistics and bioinformatics can apply, and will have to take an aptitude test an...
- Manjushree Technopak acquires Varahi Polymers; deal estimated at Rs 350 croreThis is Manjushree Technopack’s first acquisition and will pit it directly against multinational packaging company Tetrapak.
- Cipla, Godrej recognised in Fortune 'Change the World' listOn Godrej, Fortune said the company is "marketing a simple way to vanquish an insect enemy."
- RSS affiliate flags conflict of interest in IPR panelThe latest to complain is RSS affiliate Swadeshi Jagran Manch (SJM), which has written to commerce minister Nirmala Sitharaman saying that ...
- Our priority is to access more patients — we need to adjust prices accordingly: Joaquin Duato"We believe that the stream of new products we are planning to launch may address unmet medical needs. Some medicines we have are particula...
- HCL Technologies replaces IBM as IT infra vendor of AstraZenecaHCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.
- GSK open to acquiring reasonably priced company: GSK open to acquiring reasonably priced company: Andrew Witty, CEOWitty said that Cos need to find fresh solutions to tackle issues like affordability, access & escalating research costs
- Paras fought a dozen copyright cases every yearSince the days of its first successful product Stopache in the ‘80s, Paras Pharmaceuticals has seen copycats aping its flagship brands.
- Pharma firms continue to face patent violation charges in EuropeEven after India raised concerns with EU, troubles of generic companies which export drugs to developing countries through Europe are far f...
- Glaxo SmithKline to axe 6,000 workersGlaxo SmithKline, Britain's biggest pharmaceuticals company, plans to axe around 6,000 jobs around the world as it faces up to the growing ...
- Glaxo SmithKline to axe 6,000 workersGlaxo SmithKline, Britain's biggest pharmaceuticals company, plans to axe around 6,000 jobs around the world as it faces up to the growing ...
- Shantha developing $15 cervical cancer vaccineShantha Biotechnics is developing a vaccine against a virus which causes almost all cases of cervical cancer.
Load More
